← Leaderboards
Marc David Natter
Boston Children'S Hospital
$1,057,750
Attributed
$1,057,750
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $486.8K · FY2018–25$500K$375K$250K$125K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$784,084 · 2
FDA$273,666 · 1
By mechanism
R21$709,250 · 1
U24$273,666 · 1
R13$74,834 · 1
Top collaborators
No co-investigators on record.
Most similar at Boston Children'S Hospital
Same institution · by research overlap
- Sek Won Kong$4,827,231
- Annapurna Poduri$4,100,888
- Kimberly Wiltrout$153,972
- Pamela Feliciano$1,416,383
Others in their field
Other Emerging Leaders on “Systemic Lupus Erythematosus”
- Ansuman Satpathy · Stanford University$7,721,054
- Chun Jimmie Ye · Feinstein Institute For Medical Research$7,022,503
- Jacquelyn Gorman · Oklahoma Medical Research Foundation$4,662,779
- Jan Christian Lood · University Of Washington$3,263,857
- Christopher G Parker · Scripps Florida$2,924,283
- Erin Bassford Taylor · University Of Mississippi Med Ctr$2,768,707
Research focus
Systemic Lupus ErythematosusRheumatologyResourcesSurveysUnited States National Institutes Of HealthChildhoodFundingResearch PersonnelRheumatismSiteAffectAdolescentAreaChronic Childhood ArthritisArthritisCase Report FormPhenotypic DataRegistriesAutoimmune DiseasesCollaborationsBostonDemographicsBiobankEnrollment
Grant awards (5)
Development of foundational collaborations and capabilities to advance exposome research in childhood-onset rheumatic diseases and other pediatric autoimmune conditions$222,500
R21 · FY2025 · AR · contact PI
Development of a Pediatric Rheumatology Common Data Element set (CDE) for Juvenile Idiopathic Arthritis$74,834
R13 · FY2025 · AR · contact PI
Development of Foundational Collaborations and Capabilities to Advance Exposome Research in Childhood-onset Rheumatic Diseases and other Pediatric Autoimmune Conditions$486,750
R21 · FY2023 · AR · contact PI
Expanding HL7 FHIR to support post-marketing research and surveillance within multi-source, chronic disease registries$100,000
U24 · FY2019 · FD · contact PI
Expanding HL7 FHIR to support post-marketing research and surveillance within multi-source, chronic disease registries$173,666
U24 · FY2018 · FD · contact PI